Preserving Female Fertility

  • Author: Melania Tesio
  • Published: 16 January 2013
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: PLoS One/Public Library of Science
thumbnail image: Preserving Female Fertility

The female reproductive lifespan is determined by the pool of primordial follicles, ovarian structures containing immature eggs (oocytes) which periodically mature into cells which can be fertilized. While primordial follicles are gradually and physiologically lost with age, pathological conditions or exposure to environmental chemicals can accelerate their exhaustion leading to infertility.


According to Deepak Adhikari and colleagues, University of Gothenburg, Sweden, a solution to this problem consists of the immunosuppressant drug rapamycin (pictured). The researchers demonstrated that this compound, a lipophilic macrolide inactivating mTORC1, inhibits the exhaustion of the pool of primordial follicles occurring in mice upon phosphatidylinositide 3-kinase hyper-activation. Thus, rapamycin may be used in the clinic to protect female fertility from the detrimental effects of ovotoxic agents such as chemotherapeutic drugs.


Article Views: 1463

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH